PExA
0.21 SEK
-13.69 %
Less than 1K followers
PEXA B
Spotlight Stock Market
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
-13.69 %
-24.09 %
-20.61 %
-4.59 %
+30.00 %
+36.60 %
-56.23 %
-84.65 %
-90.05 %
PExA offers a patented, non-invasive technology to collect biomarkers from the small airways of the lung via exhaled air. The method is used globally by universities, hospitals, pharmaceutical companies, CROs and government agencies in the US and Europe, among others – in research on asthma, COPD, lung cancer, occupational exposure and pharmacokinetics. The company's goal is to enable earlier diagnosis and screening of lung diseases. PExA was founded in 2014 and is headquartered in Gothenburg.
Read moreMarket cap
25.82M SEK
Turnover
5.31K SEK
Revenue
477.68K
EBIT %
-1,322.21 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
Revenue M
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
22/5
2026
Interim report Q1'26
28/5
2026
General meeting '26
28/8
2026
Interim report Q2'26
All
Press releases
ShowingAll content types
PExA AB erhåller order från norska statens arbeidsmiljøinstitutt, STAMI, för arbetsmiljöstudie inom slakteriindustrin
PExA:s grundare intervjuad i Göteborgs-Posten - fokus på tidig upptäckt av lungsjukdom
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools